Compounds > fentanyl

fentanyl and sincalide

fentanyl has been researched along with sincalide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Chen, SZ; Han, JS1
Han, JS; Han, NL; Zhang, LJ1
Han, JS; Sun, YH; Zhang, ZW; Zhou, Y1
Han, JS; Kang, HG; Li, CQ; Liu, NJ; Xu, C; Xu, T; Yu, YX1

Other Studies

6 other study(ies) available for fentanyl and sincalide

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Protein c-fos induction in rat brain and spinal dorsal horn by sincalide and opioids in vitro.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1994, Volume: 15, Issue:5

    Topics: Animals; Brain; Dynorphins; Fentanyl; Peptide Fragments; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sincalide; Spinal Cord

1994
Regulation by lithium of the antagonistic effect of cholecystokinin octapeptide on ohmefentanyl-induced antinociception.
    Neuropharmacology, 1994, Volume: 33, Issue:1

    Topics: Analgesics; Animals; Fentanyl; Injections, Spinal; Lithium; Male; Nociceptors; Pain Measurement; Phosphatidylinositols; Rats; Rats, Wistar; Receptors, Opioid, mu; Sincalide

1994
Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Analgesia; Analgesics; Animals; Benzodiazepinones; Devazepide; Dose-Response Relationship, Drug; Fentanyl; Injections, Spinal; Male; Morphine; Naloxone; Nociceptors; Pain Threshold; Phenylurea Compounds; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Receptors, Opioid, mu; Sincalide; Spinal Cord; Subarachnoid Space

1993
Cholecystokinin octapeptide reverses mu-opioid-receptor-mediated inhibition of calcium current in rat dorsal root ganglion neurons.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:3

    Topics: Animals; Calcium Channel Blockers; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Fentanyl; Ganglia, Spinal; Ion Channel Gating; Male; Neurons; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Sincalide

1995